405 related articles for article (PubMed ID: 29178575)
41. Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy.
Tomino Y; Sakai H; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y
Am J Nephrol; 1986; 6(3):187-92. PubMed ID: 3526892
[TBL] [Abstract][Full Text] [Related]
42. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.
; Cattran DC; Coppo R; Cook HT; Feehally J; Roberts IS; Troyanov S; Alpers CE; Amore A; Barratt J; Berthoux F; Bonsib S; Bruijn JA; D'Agati V; D'Amico G; Emancipator S; Emma F; Ferrario F; Fervenza FC; Florquin S; Fogo A; Geddes CC; Groene HJ; Haas M; Herzenberg AM; Hill PA; Hogg RJ; Hsu SI; Jennette JC; Joh K; Julian BA; Kawamura T; Lai FM; Leung CB; Li LS; Li PK; Liu ZH; Mackinnon B; Mezzano S; Schena FP; Tomino Y; Walker PD; Wang H; Weening JJ; Yoshikawa N; Zhang H
Kidney Int; 2009 Sep; 76(5):534-45. PubMed ID: 19571791
[TBL] [Abstract][Full Text] [Related]
43. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of glomerular C4d staining in patients with IgA nephritis.
Sahin OZ; Yavas H; Taslı F; Gibyeli DG; Ersoy R; Uzum A; Cirit M
Int J Clin Exp Pathol; 2014; 7(6):3299-304. PubMed ID: 25031752
[TBL] [Abstract][Full Text] [Related]
45. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
46. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
47. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
48. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
49. The number of CD10-positive glomerular epithelial cells reflects renal prognosis in IgA nephropathy patients.
Sasaoka A; Nishiya K; Hosokawa T; Ito H; Hashimoto K; Enzan H
Clin Nephrol; 2003 Nov; 60(5):305-14. PubMed ID: 14640235
[TBL] [Abstract][Full Text] [Related]
50. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
Emancipator SN; Ovary Z; Lamm ME
Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
[TBL] [Abstract][Full Text] [Related]
51. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
[TBL] [Abstract][Full Text] [Related]
52. Coexistence of IgA nephropathy and membranous nephropathy.
Kobayashi Y; Fujii K; Hiki Y; Chen XM
Acta Pathol Jpn; 1985 Sep; 35(5):1293-9. PubMed ID: 3909735
[TBL] [Abstract][Full Text] [Related]
53. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy.
Kusano T; Takano H; Kang D; Nagahama K; Aoki M; Morita M; Kaneko T; Tsuruoka S; Shimizu A
Hum Pathol; 2016 Mar; 49():135-44. PubMed ID: 26826420
[TBL] [Abstract][Full Text] [Related]
54. [Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis].
Kaneko T; Arima R; Arakawa Y; Aoki M; Fukuda K; Fukui M; Hirama A; Fujita E; Mii A; Utsumi K; Shimizu A; Iino Y
Nihon Jinzo Gakkai Shi; 2011; 53(1):60-7. PubMed ID: 21370579
[TBL] [Abstract][Full Text] [Related]
55. Immunofluorescent studies on IgA nephropathy: type IV collagen and glomerular basement membrane component detected by Goodpasture's syndrome serum and laminin.
Tomino Y; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1988 Aug; 13(3):137-43. PubMed ID: 3075823
[TBL] [Abstract][Full Text] [Related]
56. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
57. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
Montinaro V; Esparza AR; Cavallo T; Rifai A
Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
[TBL] [Abstract][Full Text] [Related]
58. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
59. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
Haas M
Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401
[TBL] [Abstract][Full Text] [Related]
60. [Clinicopathologic features of membranous nephropathy coexisting with IgA nephropathy].
Wang SX; Zou WZ; Yang L; Zhao MH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):171-4. PubMed ID: 17535683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
